# EWTX (Edgewise Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Edgewise Therapeutics, Inc. reported $1.78B in total assets and net income of $1.01B through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/EWTX
- Markdown: https://convexityos.com/fundamentals/EWTX.md
- SEC CIK: 0001710072
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001710072&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$218.2M | Operating profit |
| Net Income | FY 2025 | $1.01B | GAAP bottom line |
| Diluted EPS | FY 2025 | $8.35 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$202.3M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $68.68M | Total debt: $3.38M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $151.4M | $127.0M | $90.91M | $54.03M | $32.19M | $14.98M |
| Total Operating Expenses | $191.4M | $158.8M | $114.4M | $71.66M | $43.22M | $17.19M |
| **Operating Income** | -$191.4M | -$158.8M | -$114.4M | -$71.66M | -$43.22M | -$17.19M |
| **EBITDA** | -$189.3M | -$156.8M | -$112.8M | -$71.29M | -$42.94M | -$17.01M |
| Interest Income | $23.61M | $25.02M | $14.19M | $4.02M | $402K | $69K |
| Income Before Tax | -$167.8M | -$133.8M | -$100.2M | -- | -- | -- |
| Income Tax Expense | $4.0K | $3.0K | $4.0K | $0 | $0 | -- |
| **Net Income** | -$167.8M | -$133.8M | -$100.2M | -$67.64M | -$42.81M | -$17.12M |
| Basic EPS | -$1.63 | -$1.45 | -$1.57 | -$1.26 | -$1.14 | -$23.17 |
| **Diluted EPS** | -$1.63 | -$1.45 | -$1.57 | -$1.26 | -$1.14 | -$23.17 |
| Basic Shares Outstanding | 102.9M | 92.4M | 63.7M | 53.6M | 37.5M | 739.0K |
| Diluted Shares Outstanding | 102.9M | 92.4M | 63.7M | 53.6M | 37.5M | 739.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $31.57M | $47.55M | $42.65M | $43.59M | $37.48M | $33.56M | $36.76M | $36.37M |
| Total Operating Expenses | $46.14M | $61.94M | $54.12M | $55.98M | $46.86M | $42.61M | $45.96M | $45.54M |
| **Operating Income** | -$46.14M | -$61.94M | -$54.12M | -$55.98M | -$46.86M | -$42.61M | -$45.96M | -$45.54M |
| **EBITDA** | -$45.64M | -$61.44M | -$53.58M | -$55.45M | -$46.36M | -$42.11M | -$45.45M | -$44.96M |
| Interest Income | $16.50M | $4.62M | $5.10M | $5.76M | $6.19M | $6.50M | $5.16M | $5.88M |
| Income Before Tax | $1.32B | -- | -- | -- | -$40.67M | -- | -- | -- |
| Income Tax Expense | $155.3M | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | $1.17B | -$57.33M | -$49.01M | -$50.22M | -$40.67M | -$36.12M | -$40.80M | -$39.66M |
| Basic EPS | $10.71 | -$0.53 | -$0.46 | -- | -$0.39 | -$0.34 | -$0.43 | -- |
| **Diluted EPS** | $9.65 | -$0.53 | -$0.46 | -- | -$0.39 | -$0.34 | -$0.43 | -- |
| Basic Shares Outstanding | 108.9M | 107.7M | 107.1M | -- | 105.5M | 104.9M | 95.1M | -- |
| Diluted Shares Outstanding | 120.9M | 107.7M | 107.1M | -- | 105.5M | 104.9M | 95.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $61.15M | $41.67M | $86.10M | $21.99M | $15.57M | $104.9M |
| **Cash & Short-Term Investments** | $61.15M | $41.67M | $86.10M | $21.99M | $15.57M | $104.9M |
| **Total Current Assets** | $543.4M | $475.5M | $327.0M | $357.0M | $283.8M | $129.6M |
| Property, Plant & Equipment, Net | $7.83M | $9.50M | $10.44M | $8.53M | $912K | $516K |
| Other Non-Current Assets | -- | $262K | $348K | $251K | $548K | $975K |
| **Total Non-Current Assets** | $9.22M | $11.33M | $13.04M | $10.10M | $1.46M | $1.49M |
| **Total Assets** | $552.6M | $486.8M | $340.0M | $367.1M | $285.2M | $131.1M |
| Accounts Payable | $6.01M | $5.58M | $4.03M | $6.11M | $3.84M | $1.58M |
| **Total Current Liabilities** | $27.37M | $23.86M | $16.77M | $16.59M | $10.52M | $4.34M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $329K | -- |
| **Total Non-Current Liabilities** | $2.98M | $3.74M | $4.43M | $3.80M | $329K | $0 |
| **Total Liabilities** | $30.35M | $27.60M | $21.20M | $20.39M | $10.85M | $4.34M |
| **Total Debt (incl. Leases)** | $3.99M | $4.74M | $5.41M | $4.41M | -- | -- |
| Common Stock | $10K | $9.0K | $7.0K | $6.0K | $5.0K | -- |
| Retained Earnings | -$546.4M | -$378.6M | -$244.8M | -$144.6M | -$76.96M | -$34.15M |
| Accumulated Other Comp. Income | $677K | $420K | $99K | -$1.35M | -$514K | -- |
| **Total Stockholders' Equity** | $522.3M | $459.2M | $318.8M | $346.7M | $274.4M | -$33.42M |
| Total Equity | $522.3M | $459.2M | $318.8M | $346.7M | $274.4M | -$33.42M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $68.68M | $72.32M | $33.21M | $61.15M | $46.00M | $43.40M | $49.92M | $41.67M |
| **Cash & Short-Term Investments** | $68.68M | $72.32M | $33.21M | $61.15M | $46.00M | $43.40M | $49.92M | $41.67M |
| **Total Current Assets** | $1.77B | $471.5M | $509.8M | $543.4M | $573.9M | $603.3M | $443.2M | $475.5M |
| Property, Plant & Equipment, Net | $6.33M | $6.89M | $7.40M | $7.83M | $8.13M | $8.60M | $8.99M | $9.50M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $695K | $262K |
| **Total Non-Current Assets** | $7.55M | $8.17M | $8.73M | $9.22M | $9.57M | $10.08M | $11.21M | $11.33M |
| **Total Assets** | $1.78B | $479.7M | $518.5M | $552.6M | $583.5M | $613.3M | $454.4M | $486.8M |
| Accounts Payable | $9.64M | $4.67M | $7.29M | $6.01M | $6.16M | $8.32M | $8.79M | $5.58M |
| Deferred Revenue (Current) | $5.20M | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $144.1M | $29.04M | $22.54M | $27.37M | $21.65M | $20.90M | $21.11M | $23.86M |
| Deferred Revenue (Non-Current) | $900K | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $888K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $3.25M | $2.57M | $2.78M | $2.98M | $3.17M | $3.37M | $3.56M | $3.74M |
| **Total Liabilities** | $147.4M | $31.61M | $25.32M | $30.35M | $24.82M | $24.26M | $24.67M | $27.60M |
| **Total Debt (incl. Leases)** | $3.38M | $3.59M | $3.79M | $3.99M | $4.18M | $4.37M | $4.56M | $4.74M |
| Common Stock | $10K | $10K | $10K | $10K | $10K | $10K | $9.0K | $9.0K |
| Retained Earnings | $513.4M | -$652.7M | -$595.4M | -$546.4M | -$496.2M | -$455.5M | -$419.4M | -$378.6M |
| Accumulated Other Comp. Income | -$5.60M | -$500K | -$252K | $677K | $701K | $204K | $401K | $420K |
| **Total Stockholders' Equity** | $1.63B | $448.1M | $493.2M | $522.3M | $558.6M | $589.1M | $429.7M | $459.2M |
| Total Equity | $1.63B | $448.1M | $493.2M | $522.3M | $558.6M | $589.1M | $429.7M | $459.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$167.8M | -$133.8M | -$100.2M | -$67.64M | -$42.81M | -$17.12M |
| Depreciation & Amortization | $2.08M | $2.07M | $1.55M | $368K | $272K | $185K |
| Stock-Based Compensation | $34.75M | $24.71M | $17.56M | $10.92M | $4.40M | $354K |
| Change in Payables | $272K | $1.74M | -$92K | $47K | $2.65M | $521K |
| **Operating Cash Flow** | -$143.8M | -$109.0M | -$91.95M | -$52.63M | -$33.51M | -$14.63M |
| Capital Expenditure | -$256K | -$1.31M | -$5.75M | -$5.55M | -$668K | -$203K |
| **Free Cash Flow** | -$144.1M | -$110.3M | -$97.69M | -$58.18M | -$34.17M | -$14.84M |
| Purchases of Investments | -$527.2M | -$477.1M | -$255.9M | -$292.4M | -$288.2M | -$24.18M |
| **Investing Cash Flow** | -$32.79M | -$184.7M | $102.9M | -$70.58M | -$242.2M | -$24.38M |
| Common Stock Issued | $187.4M | $239.1M | $52.62M | $129.2M | -- | -- |
| **Financing Cash Flow** | $196.1M | $249.3M | $53.17M | $129.6M | $186.4M | $120.3M |
| **Net Change in Cash** | $19.48M | -$44.43M | $64.10M | $6.43M | -$89.35M | $81.26M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $1.17B | -$57.33M | -$49.01M | -$50.22M | -$40.67M | -$36.12M | -$40.80M | -$39.66M |
| Depreciation & Amortization | $500K | $500K | $537K | $525K | $500K | $500K | $513K | $577K |
| Stock-Based Compensation | $8.56M | $9.36M | $8.71M | $9.88M | $8.09M | $7.73M | $9.06M | $7.74M |
| Change in Payables | $6.60M | $781K | $1.45M | -$303K | -$2.13M | -$151K | $2.86M | $92K |
| **Operating Cash Flow** | -$78.29M | -$42.47M | -$42.54M | -$38.59M | -$34.78M | -$32.58M | -$37.87M | -$26.96M |
| Capital Expenditure | -$17K | -$32K | -$260K | -$73K | -$89K | -$50K | -$44K | -$274K |
| **Free Cash Flow** | -$78.31M | -$42.50M | -$42.80M | -$38.66M | -$34.87M | -$32.63M | -$37.91M | -$27.23M |
| Purchases of Investments | -$1.40B | -$53.09M | -$110.2M | -$74.28M | -$67.00M | -$263.8M | -$122.2M | -$63.18M |
| **Investing Cash Flow** | $59.67M | $78.49M | $2.43M | $49.76M | $35.72M | -$162.2M | $43.90M | $20.92M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $14.98M | $3.09M | $12.17M | $3.98M | $1.66M | $188.2M | $2.22M | $2.90M |
| **Net Change in Cash** | -$3.64M | $39.11M | -$27.94M | $15.14M | $2.60M | -$6.52M | $8.26M | -$3.14M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -32.1% | -29.1% | -31.4% | -19.5% | -15.6% | -- |
| Return on Assets (ROA) | -30.4% | -27.5% | -29.5% | -18.4% | -15.0% | -13.1% |
| Current Ratio | 19.85x | 19.93x | 19.50x | 21.53x | 26.97x | 29.86x |
| Quick Ratio | 2.23x | 1.75x | 5.13x | 1.33x | 1.48x | 24.16x |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.01x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 61.8% | -44.0% | -35.7% | -32.1% | -28.1% | -25.6% | -34.0% | -29.1% |
| Return on Assets (ROA) | 56.7% | -41.1% | -33.9% | -30.4% | -26.9% | -24.6% | -32.1% | -27.5% |
| Current Ratio | 12.30x | 16.24x | 22.61x | 19.85x | 26.51x | 28.87x | 20.99x | 19.93x |
| Quick Ratio | 0.48x | 2.49x | 1.47x | 2.23x | 2.13x | 2.08x | 2.36x | 1.75x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
